CO4750644A1 - NEW STABLE MEDICATION PREPARATION FOR THE PRODUCTION OF PROPELLER-FREE GAS AEROSOLS - Google Patents

NEW STABLE MEDICATION PREPARATION FOR THE PRODUCTION OF PROPELLER-FREE GAS AEROSOLS

Info

Publication number
CO4750644A1
CO4750644A1 CO96033541A CO96033541A CO4750644A1 CO 4750644 A1 CO4750644 A1 CO 4750644A1 CO 96033541 A CO96033541 A CO 96033541A CO 96033541 A CO96033541 A CO 96033541A CO 4750644 A1 CO4750644 A1 CO 4750644A1
Authority
CO
Colombia
Prior art keywords
preparation according
medicated
preparation
ethanol
solvent
Prior art date
Application number
CO96033541A
Other languages
Spanish (es)
Inventor
Bernhard Freund
Michael Kruger
Bernd Zierenberg
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Priority to CO96033541A priority Critical patent/CO4750644A1/en
Publication of CO4750644A1 publication Critical patent/CO4750644A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Preparado medicamentoso para producir aerosoles 5 exentos de gaspropulsor que contiene una sustancia farmacológicamente activa así como eventualmente coadyuvantes y/o sustancias saboreantes farmacológicamente inocuos, caracterizado porque el preparado medicamentoso contiene como disolvente etanol al menos al 70% (v/v). Preparado medicamentoso según la reivindicación 1, caracterizado porque como disolvente contiene etanol al 96% (v/v). Preparado medicamentoso según la reivindicación 1 o 2, caracterizado porque la sustancia activa está determinada para la aplicación por inhalación y se compone del grupo de los betamiméticos, anticolinérgicos, antialérgicos y/o antagonistas de PAF. Preparado medicamentos para producir aerosoles exentos de gas propulsor que contienen un esteroide así como eventualmente coadyuvantes y/o sustancias saboreantes farmacológicamente inocuos, caracterizado porque el preparado medicamentoso contiene como disolvente etanol al menos al 85% (v/v) y eventualmente un formador de complejos. Preparado medicamentoso según la reivindicación 4, caracterizado porque el disolvente es etanol al 96% (v/v). Preparado medicamentoso según la reivindicación 5, caracterizado porque el formador de complejos es EDTA o una sal del mismo. Preparado medicamentoso según la reivindicación 4 o 6, caracterizado porque la cantidad de formador de complejos oscila entre 0,1 y 5 mg/100 ml de solución. Preparado medicamentoso según una de las reivindicaciones 4 a 7, caracterizado porque el valor del pH del preparado está ajustado a un valor entre 3,2 y 4,5.Drug preparation to produce gas-propellant-free aerosols containing a pharmacologically active substance as well as possibly adjuvants and / or pharmacologically safe flavoring substances, characterized in that the drug preparation contains at least 70% (v / v) ethanol solvent. Medicated preparation according to claim 1, characterized in that it contains 96% (v / v) ethanol as a solvent. Medicated preparation according to claim 1 or 2, characterized in that the active substance is determined for the application by inhalation and is made up of the group of betamimetics, anticholinergics, antiallergics and / or PAF antagonists. Drug preparation to produce propellant gas-free aerosols containing a steroid as well as possibly adjuvants and / or pharmacologically safe flavoring substances, characterized in that the drug preparation contains at least 85% (v / v) ethanol and eventually a complex-forming solvent. . Medicated preparation according to claim 4, characterized in that the solvent is 96% (v / v) ethanol. Drug preparation according to claim 5, characterized in that the complexer is EDTA or a salt thereof. Medicated preparation according to claim 4 or 6, characterized in that the amount of complex former ranges from 0.1 to 5 mg / 100 ml of solution. Medicated preparation according to one of claims 4 to 7, characterized in that the pH value of the preparation is adjusted to a value between 3.2 and 4.5.

CO96033541A 1996-06-26 1996-06-26 NEW STABLE MEDICATION PREPARATION FOR THE PRODUCTION OF PROPELLER-FREE GAS AEROSOLS CO4750644A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CO96033541A CO4750644A1 (en) 1996-06-26 1996-06-26 NEW STABLE MEDICATION PREPARATION FOR THE PRODUCTION OF PROPELLER-FREE GAS AEROSOLS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CO96033541A CO4750644A1 (en) 1996-06-26 1996-06-26 NEW STABLE MEDICATION PREPARATION FOR THE PRODUCTION OF PROPELLER-FREE GAS AEROSOLS

Publications (1)

Publication Number Publication Date
CO4750644A1 true CO4750644A1 (en) 1999-03-31

Family

ID=40930130

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96033541A CO4750644A1 (en) 1996-06-26 1996-06-26 NEW STABLE MEDICATION PREPARATION FOR THE PRODUCTION OF PROPELLER-FREE GAS AEROSOLS

Country Status (1)

Country Link
CO (1) CO4750644A1 (en)

Similar Documents

Publication Publication Date Title
AR002614A1 (en) NEW STABLE MEDICATION PREPARATION FOR THE PRODUCTION OF PROPELLER-FREE GAS AEROSOLS
UY24813A1 (en) NEW AQUEOUS MEDICATION PREPARATIONS FOR THE PRODUCTION OF GAS PROPELLER FREE SPRAYS
AR033444A1 (en) SOLID DOSAGE FORM FOR THE ORAL ADMINISTRATION OF AN ACTIVE NICOTINE COMPOUND, THROUGH THE MUCOSE AND USE OF AN ACTIVE NICOTINE COMPOUND TO PREPARE IT
EE200300033A (en) Cyclopentanoindoles, their use in the preparation of a medicament, and the pharmaceutical composition containing them
DE60114571D1 (en) PREPARATIONS WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE
RU98101470A (en) NEW STABLE MEDICINAL COMPOSITION FOR PRODUCING AEROSOLS OF WORKING GAS
RU94040387A (en) Nicotine-containing composition
BG105033A (en) Pharmaceutical formulations for aerosols with two or more active substances
MD1813B2 (en) Purified cyclodextrin derivatives of sulphoalkyl ethers or mixtures thereof, clathrate complex of cyclodextrin derivatives with medicamental content and pharmaceutical composition
SE0003449D0 (en) Anticancer compositions
AR046533A1 (en) FORMULATION OF AEROSOL INTENDED FOR INHALATION, CONTAINING AN ANTI-POLINERGIC AGENT
EA199900991A1 (en) MEDICAL SPRAY PREPARATIONS
NO962841D0 (en) Use of 2-hydroxy-5-phenylazobenzoic acid derivatives such as colon cancer chemopreventives and chemotherapeutic agents
KR960700061A (en) PHARMACEUTICAL COMPOSITION FOR TREATING NICOTINE DEPENDENCE
ATE202931T1 (en) MEDICINAL PREPARATIONS CONTAINING TAXAN DERIVATIVES
AR006401A1 (en) PIRROLOPYROLONE COMPOUNDS, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT AND IN THERAPY, PROCESSES FOR ITS PREPARATION AND INTERMEDIARY COMPOUNDS FOR SUCH PROCESSES.
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
EA200701805A1 (en) COMPOSITION OF AEROSOL FOR DOSING INHALERS UNDER PRESSURE
ES2171459T3 (en) NASAL ADMINISTRATION POWDER FOR PEPTIDIC PHARMACO OR PROTEINACEO.
CO4750644A1 (en) NEW STABLE MEDICATION PREPARATION FOR THE PRODUCTION OF PROPELLER-FREE GAS AEROSOLS
MXPA05006528A (en) Process for preparing combination pharmaceutical formulations using supercritical fluids.
AR012826A1 (en) BIS-PLATINUM (II) COMPLEX, METHOD FOR PREPARING SUCH A COMPLEX AND USE OF THE SAME COMPLEX IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION TO TREAT TUMORS.
MXPA04000007A (en) Use of 2,5-dihydroxybenzenesulphonic acid derivatives in the production of a medicament used to potentiate the effect of other drugs in the treatment of erectile dysfunction.
SE9403389D0 (en) Pharmaceutical composition containing derivatives of sex hormones
ES8200678A1 (en) Dibenzazepine derivatives, their production and pharmaceutical compositions containing them.